# OnCo record thyroid-cancer-markers (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/thyroid-cancer-markers/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "thyroid-cancer-markers" ;
  schema:name "Thyroglobulin, calcitonin and CEA in thyroid cancer follow-up"@en ;
  schema:alternateName "thyroglobulin"@en, "calcitonin"@en, "calcitonin doubling time"@en, "thyroglobulin antibodies"@en, "thyroid cancer blood tests"@en ;
  schema:description "After the thyroid is removed for cancer, a blood protein it alone makes, thyroglobulin, should fall to nothing, so any measurable level in follow-up means cancer is still there; in medullary thyroid cancer the same job is done by calcitonin and CEA, whose doubling time forecasts how fast the disease will move."@en ;
  schema:url <https://onco.cc/technologies/thyroid-cancer-markers/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1089/thy.2015.0020>, <https://doi.org/10.1089/thy.2014.0335> ;
  onco:status "standard-of-care" ;
  onco:cancers <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/papillary-thyroid-cancer/>, <https://onco.cc/cancers/follicular-thyroid-cancer/>, <https://onco.cc/cancers/medullary-thyroid-cancer/>, <https://onco.cc/cancers/multiple-endocrine-neoplasia/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/serum-tumour-markers/>, <https://onco.cc/technologies/germ-cell-tumour-markers/>, <https://onco.cc/technologies/cea-surveillance-colorectal/>, <https://onco.cc/technologies/thyroid-fna-molecular/>, <https://onco.cc/technologies/ultrasound/>, <https://onco.cc/technologies/hand-held-ultrasound/> ;
  onco:targets <https://onco.cc/targets/ret/>, <https://onco.cc/targets/ceacam5/> ;
  onco:drugs <https://onco.cc/drugs/selpercatinib/>, <https://onco.cc/drugs/vandetanib/>, <https://onco.cc/drugs/cabozantinib/> ;
  onco:terms <https://onco.cc/terms/tumour-marker/>, <https://onco.cc/terms/tumour-markers/>, <https://onco.cc/terms/thyroidectomy/>, <https://onco.cc/drugs/radioactive-iodine/> .
